WHAT THE CELL REMEMBERS

This book begins with a problem of identity. A living medicine is not a stable object that can always be described independently of the route by which it was made, handled, and administered. Its history matters. The argument follows that fact through biological identity, clinical proof, regulatory decisions, publication, payment, consent, and long-term responsibility.

Part One asks what kind of object a cellular treatment is. Part Two examines what that object does to clinical evidence. Part Three considers the institutions that must decide whether a product can be trusted, delivered, paid for, and explained to a patient.

Each of the eighteen chapters preserves the original argument while adding a new section grounded in current public records. The appendices then extend the discussion into product-level teaching files, institutional decisions, source interpretation, patient handoffs, research questions, and a working glossary.